Evaluation of Factors Affecting Antiretroviral Treatment Changes in HIV- Positive Patients in a University Hospital

被引:0
作者
Cakir, Yasemin [1 ]
Ince, Nevin [2 ]
Caliskan, Emel [3 ]
Tunca, Bekir [4 ]
Yekenkurul, Dilek [2 ]
机构
[1] Bozok Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Yozgat, Turkiye
[2] Duzce Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Duzce, Turkiye
[3] Duzce Univ, Dept Med Microbiol, Fac Med, Duzce, Turkiye
[4] Ankara Univ, Dept Publ Hlth, Fac Med, Ankara, Turkiye
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2023年 / 28卷 / 01期
关键词
ART; HIV; AIDS; Side effect; MYOCARDIAL-INFARCTION; THERAPY; RISK;
D O I
10.5578/flora.20239617
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is the leading cause of death from infectious diseases in the world. With the antiretroviral treatments developed over the years, viral replication is suppressed even though the disease cannot be cured yet. However, antiretroviral therapy (ART), like all drugs, has brought with it undesirable side effects as well as positive effects. In addition, demographic characteristics, accompanying comorbidities, organ dysfunctions, viral load, CD4 T lymphocyte count, ART resistance status, coinfections, pregnancy are also effective factors in the initial ART decision and change. In this study, we aimed to show the treatment status of HIV-positive patients followed in the infectious diseases outpatient clinic of our hospital and to determine the factors that affect ART change. Materials and Methods: Demographic data of HIV-positive patients followed in the infectious diseases outpatient clinic between January 2016 and May 2021, HIV-RNA and CD4 T lymphocyte results obtained before and after antiretroviral therapy, and the reasons for changing treatment were evaluated retrospectively. Results: The mean age of the patients included in the study was 40.0 +/- 13.9 (min: 20-max: 76), and 16 (18%) were female and 71 (82%) were male. Treatment was changed in 32% of the patients. Changes were made due to drug-related side effects in 43%, patient-related reasons (such as single tablet request, non-compliance with treatment) in 25%, and virological unresponsiveness in 18% of patients who underwent treatment change. The most common cause of drug changes due to side effects was hyperlipidemia. The treatment regimens that changed the initial treatment were most frequently TDF/FTC/LPV/r and TDF/FTC/EFV, respectively. Conclusion: As a result of our study, we found that the most common cause of ART change in HIV-positive patients in our hospital was drug-related side effects, and patient non-compliance was the second most common. It is important to know the factors that cause these changes in advance and to make choices accordingly when starting the treatment, in order to increase patient compliance and facilitate follow-up.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 16 条
  • [1] Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults
    Althoff, Keri N.
    McGinnis, Kathleen A.
    Wyatt, Christina M.
    Freiberg, Matthew S.
    Gilbert, Cynthia
    Oursler, Krisann K.
    Rimland, David
    Rodriguez-Barradas, Maria C.
    Dubrow, Robert
    Park, Lesley S.
    Skanderson, Melissa
    Shiels, Meredith S.
    Gange, Stephen J.
    Gebo, Kelly A.
    Justice, Amy C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) : 627 - 638
  • [2] Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
    Bedimo, Roger
    Maalouf, Naim M.
    Zhang, Song
    Drechsler, Henning
    Tebas, Pablo
    [J]. AIDS, 2012, 26 (07) : 825 - 831
  • [3] Comparison of Antiretroviral Therapy Regimens in Terms of Virological Response, Immunological Response and Adverse Effects in Treatment-Naive HIV-Positive Patients
    Benli, Aysun
    Basaran, Seniha
    Simsek-Yavuz, Serap
    Cagatay, Atahan
    Oncul, Oral
    Ozsut, Halit
    Eraksoy, Haluk
    [J]. KLIMIK JOURNAL, 2018, 31 (02) : 94 - 100
  • [4] European AIDS Clinical Society, 2019, GUIDELINES CLIN MANA
  • [5] European AIDS Clinical Society, 2021, GUID V11 0
  • [6] European AIDS Clinical Society (EACS), 2015, GUID V8
  • [7] Comorbidities, Antiretroviral Therapy Switches, and Drug Side-Effects Among HIV-Infected Patients
    Evlice, Oguz
    Basaran, Seniha
    Simsek-Yavuz, Serap
    Cagatay, A. Atahan
    Oncul, Oral
    Ozsut, Halit
    Eraksoy, Haluk
    [J]. KLIMIK JOURNAL, 2020, 33 (03) : 241 - 247
  • [8] Inan A., 2006, TURK HIV AIDS DERG, V9, P104
  • [9] Johnson Steven C, 2016, Top Antivir Med, V23, P161
  • [10] Karaosmanoglu-Kumbasar H, 2013, PAM TIP DERG, V6, P118, DOI [10.5505/ptd.2013.21033, DOI 10.5505/PTD.2013.21033]